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Combinatorial chemistry, which did
not even exist fifteen years ago, is a
new subfield of chemistry that is
starting to provide insights into
molecular interactions, biochemical
catalysis and drug development.
Instead of finding and testing
naturally existing compounds for
useful activity, the basic aim of
combinatorial chemistry studies is to
create vast numbers of new,
synthetic compounds and screen
them for activity, to identify
molecules on the basis of function
(see green box).
Diverse collections of some
biological macromolecules (for
example, phage display peptide
libraries, antibody libraries and
oligonucleotide libraries) can be
created via biosynthetic methods but
such work is more commonly referred
to as ‘combinatorial biochemistry’. By
contrast, combinatorial chemistry
uses synthetic chemistry methods to
generate organized collections, or
libraries, of compounds including
peptides and small organic molecules.
This Primer will focus on
combinatorial chemistry.
The earliest work in combinatorial
chemistry was aimed at discovering
ligands for biological macromolecules,
such as proteins. Such ligands can be
useful tools in understanding the
structure and function of proteins
and, if the ligand meets certain
physiochemical constraints, it might
be useful as a drug.
One strategy at the heart of
combinatorial chemistry is the
concept of combining chemical
building blocks, like ‘beads on a
string’, in all possible combinations.
This is sometimes referred to as
‘matrix chemistry’. If a chemical
synthesis route consists of three
discrete steps, each employing one
class of reagent to accomplish the
conversion, then employing one
type of each reagent class will yield
1 × 1 × 1 = 1 product as the result of
1 + 1 + 1 = 3 total reactions.
Combining 10 types of each reagent
class will yield 1,000 products as the
result of as few as 30 total reactions;
100 types of each reagent will yield
1,000,000 products as the result of as
few as 300 total reactions. Although
conceptually simple, considerable
strategy is required to identify
1,000,000 products worth making,
and to carry out their synthesis in a
manner that minimizes labor and
maximizes the value of the resulting
organized collection, called a
chemical library.
The central approach of
combinatorial chemistry — and one
which involves a paradigm shift for
most organic chemists — is to start
with a source of molecular diversity
(that is, lots of compounds) organized
in a way that makes their empirical
testing straightforward, then test
them all and analyze the results at
the end. This approach is well
illustrated by the development of
peptide libraries to study
ligand–receptor binding.
Peptide libraries
By synthesizing a large number of
peptides, each varying from another
by only one amino acid, it is possible
to determine empirically which amino
acid substitutions make binding to a
macromolecular receptor stronger and
which make it weaker. The problem
is how to conveniently make
thousands of peptides in a format that
can be easily used in the subsequent
binding studies. One solution is to
synthesize the peptides on a rack of
plastic pins (usually called Geysen
pins), and to test their binding ability
while the peptides remain chemically
attached to the pin.
Because there are 20 naturally
occurring amino acids, the synthesis
of a linear peptide n amino acids long
can be done in 20n different ways.
Thus, there are 64,000,000 possible
hexapeptides. It would not be
convenient, perhaps not even
possible, to synthesize that many
peptides on individual pins. An
alternative to synthesis on pins is to
encase the plastic support used for
synthesis in an inert mesh resembling
a tea-bag. Collections of such ‘tea-
bag’ reactors are subjected to the
chemical addition of an amino acid at
the same time. After the addition, the
tea-bags are washed thoroughly and
the bags (not the bag contents)
mixed. The bags are redistributed to
new beakers and another amino acid
chemically added. In this method,
each tea-bag contains only one
peptide, which can be obtained by
chemically cleaving it from the
polymeric support. This type of
divide–couple–recombine approach is
known as split-pool synthesis.
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The goal of combinatorial chemistry is to
synthesize very large numbers of chemical
entities by condensing a small number of
reagents together in all combinations
defined by a given reaction sequence. A
single starting material is subjected to a
library synthesis route, using a range of
reagents in each diversity step. The
resulting collection of library members may
contain from a few hundred to millions of
samples. Automated sample distribution
provides microtiter plates ready for the
screen. After addition of all the ‘constant’
components for the screening reaction,
followed by incubation, the results of each
assay are read using absorbance,
fluorescence, or radioactivity.
Because there is only one compound
per aliquot of solid phase support,
individual compounds are easily isolated.
In the case of peptides, the structure of a
promising compound can be determined
from the individual 200 picomole sample.
But organic compounds must be tagged
during synthesis so that the reaction
history of any promising compound is
known, allowing its identity to be
determined.
Synthesis and use of a combinatorial library
To make large numbers of
individual peptides would require
impossibly small tea-bags, for purely
practical reasons. The solution is to
use the same split-pool approach, but
with polymer resin beads, each only
microns in diameter, as a kind of tea-
bag. After addition of an individual
amino acid to separate reaction
vessels, each containing an aliquot of
the beads, all the aliquots are
recombined, then split again into
individual vessels for the next step of
the synthesis. In this way, it is
possible to synthesize large peptide
libraries in which each bead possesses
a single peptide that potentially can
be recognized selectively by a
biological target (antibody, enzyme,
or receptor). Each bead carries only
about 200 picomoles of peptide but
this is enough for both a simple
ligand–receptor binding assay and for
the analytical techniques required to
establish the exact chemical structure
of that peptide.
Organic libraries
Because much of the impetus for
discovering tightly binding ligands
derives from the pharmaceutical
industry, the combinatorial synthesis
of ‘drug-like’ (low molecular weight,
organic molecules) compound
libraries is of great interest. Two
practical considerations make this a
greater experimental challenge than
the synthesis of peptide libraries.
First, the synthetic methods
required to make drug-like molecules
on a plastic support have not been
optimized. Although solid-supported
peptide synthesis saw its origins in
the early 1960s and has been
extensively developed since then,
initial experiments with organic solid-
phase synthesis in the early 1970s
were not followed up widely. In
addition, although there are only 20
naturally occurring amino acids and
therefore a finite number of reactions
required to use them efficiently, an
enormous number of organic
chemistry reagents and a very large
number of reaction types exist. By the
early 1990s, however, the synthesis of
moderately-sized organic libraries
using the solid-phase synthesis
method had been reported. Each
approach used a strategy like that of
the pin method, and was therefore
amenable to the parallel synthesis of
hundreds to thousands of compounds.
The second consideration that
inhibited the synthesis of much
larger libraries using a
one-bead-one-compound approach
is that, whereas 200 picomoles of an
organic compound is enough for a
ligand–receptor study, it is not
enough to identify the structure of
the ligand; in other words, it’s not
easy to characterize any promising
compounds that emerge from the
screen. Recently, ‘bead tagging’, or
encoding, solved this problem. The
strategy is simple: if the result of a
chemical synthesis step cannot be
easily read at low concentration, one
should add something to the bead
that conveniently encodes the
reaction history of that bead for later
analysis. Indeed, the first reported
methods of bead encoding involved
the use of biological
macromolecules as tags. After each
organic synthesis step, either an
amino acid or a nucleotide is added
to a growing oligopeptide or
oligonucleotide on the same bead,
such that the sequence can be read
later to reveal the identity of the
tagged compound.
But neither oligopeptides nor
oligonucleotides are chemically inert
enough to survive the conditions
required in organic synthesis, so more
recent methods of encoding include
the use of radiofrequency memory
microchips and optical bar-coding
strategies. A clever method of tagging
organic compounds using stable (non-
radioactive) isotopes incorporated
either into a bead, into a chemical
linker or into the chemical backbone
of each compound allows encoding
and decoding by mass spectroscopy
(see Figure 1). For example, by
adjusting the amounts of 13C, 15N and
deuterium in a series of amino acids
that link a bead to a compound, a
ratio barcode can be embedded in the
library members, with little or no
effect on their chemical reactivity.
From flask to well
A library only brings value when
screened. The way library members
are screened for activity depends on
the form in which they are
synthesized. In most instances, the
compounds are cleaved from the
solid support on which they were
made and eluted into microtiter
plates, such that each well contains
one compound.
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Figure 1
An example of a combinatorial library design, in which chemical building blocks (reagents
A,B,C), which make up the potential compounds of the library, are attached sequentially to a
polystyrene bead (yellow) through a chemical linker (blue). Attachment of the reagents to the
linker is via an amino group (red). A optical bar code or a stable isotope ratio code can be
inserted in the linker region, and can be deciphered by mass spectroscopy. Varying ratios of
stable isotopes allow thousands of separate codes to be inserted in the linker region. In this
example, the red block represents an atom transferred into the ligand that is made up from a
varying ratio of isotopes. This and other encoding methods allow tagging of the compounds in a
combinatorial library and eventual decoding of their individual history of synthesis. (Adapted,
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For a typical high-throughput
screen, an experimenter will start
with a set of microtiter plates
containing library members. All wells
are then loaded with the constant
components (for example, target
protein, buffer, assay reagent),
incubated for the appropriate time,
and read. This method is most
appropriate when screening for
activities such as binding or catalysis
because the compounds react with a
single purified target molecule.
A variation on this method is the
use of a bead-based library. In such
libraries, the synthesis occurs on a
polystyrene bead support; each bead
contains one compound. The
synthesis is done such that the
synthetic library member is
connected to the bead via a
chemically or photochemically
cleavable linker. In this scenario, one
bead (or a small number of beads) is
placed in a well. The plate is
irradiated so that compounds are
released from the bead. All of the
constants for assay are added, and
the assay carried out.
One powerful application of such
‘releasable’ libraries is that lawn
assays on petri dishes can be
performed and local effects on living
cells observed. If an interesting
biological effect is observed
surrounding the bead containing the
released compound, the bead can be
decoded to reveal the identity of the
chemical. The released compound
can then be resynthesized for
subsequent biological experiments.
One can readily imagine the potential
of this method for the discovery of
novel antibiotics or anti-proliferative
compounds using cultured cells.
An important paradigm of
combinatorial screening is the ability
to produce secondary ‘focused’
libraries using information gained
from the primary screening libraries.
Focused libraries represent
substructures of the original primary
library. They can allow one to refine
the properties of a selected
compound, such as by increasing its
affinity of binding or catalytic rate.
Future innovation
Major challenges in combinatorial
chemistry focus on both the
compound characterisation and
screening of very large compound
libraries; some believe that it
involves statistics and mathematics
more than it does chemistry.
As combinatorial chemistry has so
recently been applied to drug
discovery, there are, as yet, no fully
developed success stories in clinical
trials to cite. It is claimed, however,
that several proprietary examples
exist which are in clinical
development and soon to be
available to the public. In theory,
combinatorial chemistry has the
potential to uncover numerous
biological agonists and antagonists. It
could also reveal a wide variety of
synthetic receptors, including
catalysts and chemosensors. Many
combinatorially-derived reagents will
prove useful in the research
laboratory for understanding basic
biological processes, and a few might
end up as drugs or drug leads.
One can imagine a tremendous
advantage of using combinatorial
libraries and high-throughput
screening to rapidly derive molecules
that inhibit or activate gene products
discovered through the international
genome projects. For example, the
genomes of many of the pathogenic
microbes, or ‘superbugs’, that are
becoming resistant to all known
antibiotics have been sequenced. As
microbes evolve antibiotic resistance
at very high rates, humans will need
robust technologies such as
combinatorial chemistry, using
genomic information, to out-evolve
the bugs’ rapid adaptation to each
generation of new antibiotics. One
can imagine similar approaches to
the treatment of diseases, using
genomic information about
cancer-susceptibility genes and genes
involved in other diseases with
complex traits. In this way, the rapid
application of combinatorial chemistry
and high-throughput screening could
conceivably allow therapies to be
customized for individual patients.
As only a very small number of
biologically-active compounds has
ever been sampled from the
universe of possible chemicals, the
potential to discover novel
biological modifiers and highly
specific drugs using combinatorial
technologies has opened a new
frontier in biology and medicine.
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